全文获取类型
收费全文 | 1764篇 |
免费 | 98篇 |
国内免费 | 81篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 95篇 |
妇产科学 | 44篇 |
基础医学 | 190篇 |
口腔科学 | 25篇 |
临床医学 | 302篇 |
内科学 | 359篇 |
皮肤病学 | 35篇 |
神经病学 | 43篇 |
特种医学 | 335篇 |
外科学 | 87篇 |
综合类 | 32篇 |
预防医学 | 171篇 |
眼科学 | 24篇 |
药学 | 101篇 |
肿瘤学 | 97篇 |
出版年
2022年 | 6篇 |
2021年 | 11篇 |
2019年 | 14篇 |
2018年 | 17篇 |
2017年 | 13篇 |
2016年 | 18篇 |
2015年 | 22篇 |
2014年 | 18篇 |
2013年 | 41篇 |
2012年 | 34篇 |
2011年 | 42篇 |
2010年 | 59篇 |
2009年 | 56篇 |
2008年 | 61篇 |
2007年 | 90篇 |
2006年 | 44篇 |
2005年 | 55篇 |
2004年 | 28篇 |
2003年 | 31篇 |
2002年 | 31篇 |
2001年 | 30篇 |
2000年 | 43篇 |
1999年 | 35篇 |
1998年 | 94篇 |
1997年 | 92篇 |
1996年 | 114篇 |
1995年 | 88篇 |
1994年 | 92篇 |
1993年 | 75篇 |
1992年 | 35篇 |
1991年 | 47篇 |
1990年 | 44篇 |
1989年 | 46篇 |
1988年 | 47篇 |
1987年 | 39篇 |
1986年 | 46篇 |
1985年 | 40篇 |
1984年 | 14篇 |
1983年 | 24篇 |
1982年 | 22篇 |
1981年 | 22篇 |
1980年 | 19篇 |
1979年 | 14篇 |
1978年 | 13篇 |
1977年 | 22篇 |
1976年 | 17篇 |
1975年 | 15篇 |
1974年 | 6篇 |
1973年 | 8篇 |
1972年 | 10篇 |
排序方式: 共有1943条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Jose S. Pulido Ikuko Sugaya Jordan Comstock Kiminobu Sugaya 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》2007,245(6):889-893
Purpose Reelin is important in the guidance of neuronal stem cells in the central nervous system during normal development. We wished
to determine whether reelin is expressed in the retina and cornea after injury.
Methods Mice underwent laceration of their retina as well as corneal epithelial debridement. The mice were sacrificed at 3 days, and
eyes were fixed and stained for reelin expression and reelin messenger ribonucleic acid (mRNA).
Results In normal eyes, reelin was expressed only at very low levels in the ganglion cell layer of the retina and the endothelial
cell layer of the cornea. In injured eyes, there was marked expression in reelin immunoreactivity in the retina and cornea.
Reelin gene expression was seen in the retina and cornea.
Conclusions Reelin is expressed during normal retinogenesis. This study shows that reelin is also upregulated following injury to the
retina and cornea. The expression of reelin following injury suggests that reelin may play an important role in regulating
stem cell trafficking in neuronal and nonneuronal tissues following injury similar to its role in normal organogenesis.
For consideration of publication in Graefe’s Archive for Clinical and Experimental Ophthalmology. 相似文献
5.
6.
7.
8.
D Rudy D A Sica T Comstock J Davis J Savory A C Schoolwerth 《The International journal of artificial organs》1991,14(10):625-629
The influence of a sodium citrate/citric acid mixture on the gastrointestinal (GI) absorption of aluminum (Al) from an Al(OH)3 preparation was evaluated in six stable maintenance hemodialysis patients. Plasma Al concentrations were determined serially after each of the following treatment sequences (I) Al(OH)3; (II) Al(OH)3 + sodium citrate/citric acid; (III) sodium citrate/citric acid; (IV) Al(OH)3 + NaHCO3. AUC0-8 for plasma Al from 0 to 8 hours was significantly greater (p less than 0.05) for Al(OH)3 + sodium citrate/citric acid (73 +/- 23 micrograms.hr/l; mean +/- SEM) than Al(OH)3 (16 +/- 30 micrograms.hr/l); sodium citrate/citric acid (-27 +/- 14 micrograms.hr/l); or Al(OH)3 + NaHCO3 (6 +/- 22 micrograms.hr/l). The 24 hour Al level remained above baseline (p less than 0.03) following Al(OH)3 + sodium citrate/citric acid (31 +/- 12 (pre) vs 54 +/- 14 micrograms/l (post), in contradistinction to study limb: l (34 +/- 14 vs 30 +/- 12 micrograms/l); III (79 +/- 40 vs 65 +/- 35 micrograms/l); and IV (71 +/- 37 vs 66 +/- 42 micrograms/l). We conclude that the GI absorption of Al from Al(OH)3 is enhanced by citrate in patients undergoing hemodialysis and that elevations of plasma Al persist longer. The concomitant administration of citrate and Al-containing phosphate (PO4) binders should be avoided in patients with end-stage renal disease (ESRD). NaHCO3 may serve as an alternative therapy for metabolic acidosis with less risk of enhancing Al absorption. 相似文献
9.
Dehydroepiandrosterone and dehydroepiandrosterone sulfate are steroids which may be associated with the development of breast cancer. To examine the association between serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate and the risk of developing premenopausal breast cancer, we measured hormone levels in 15 women who donated blood to a community-based serum bank in 1974 and who subsequently developed premenopausal breast cancer and in 29 matched controls from the same group of volunteers. The mean serum level of dehydroepiandrosterone among cases was 10% lower than among controls. The risk of developing breast cancer for women in the highest tertile compared with the lowest tertile of serum dehydroepiandrosterone was 0.40 with a suggestion of a dose-response trend with increasing levels. No consistent association between dehydroepiandrosterone sulfate and the risk of premenopausal breast cancer was evident. In contrast to postmenopausal breast cancer, a protective effect of dehydroepiandrosterone against premenopausal breast cancer is suggested, but because of the small sample size, the results of this study need to be replicated by others. 相似文献
10.
Y Leskinen JP Salenius T Lehtim?ki H Huhtala H Saha 《American journal of kidney diseases》2002,40(3):472-479
BACKGROUND: Knowledge of the prevalence of peripheral arterial disease (PAD) in patients with chronic renal failure (CRF) is limited because of a lack of uniformity in disease definition and recognition. Furthermore, little is known of the prevalence of medial arterial calcification (MAC) in patients with CRF. Our goal is to study the prevalence of PAD and MAC defined by ankle brachial index (ABI) or toe brachial index (TBI) measurements in a Finnish population of patients with CRF consisting of predialysis and dialysis patients, as well as renal transplant recipients. METHODS: We examined 136 patients with CRF and 59 control subjects. Fifty-nine of the patients with CRF had moderate to severe predialysis CRF, 36 patients were on dialysis treatment, and 41 were renal transplant recipients. Mean age of patients was 51.9 +/- 11.5 years, and 39 patients (29%) had diabetes. ABI and TBI were measured by means of photoplethysmography. The definition of PAD required an ABI value of 0.90 or less, a TBI value of 0.60 or less, or a previous positive lower-extremity angiogram result. ABI values of 1.3 or greater or incompressible arteries at ankle level indicated MAC. The presence of claudication was determined by an interview. RESULTS: Prevalences of PAD on this study were 22.0% in patients with predialysis CRF, 30.6% in patients on dialysis treatment, 14.6% in renal transplant recipients, and 1.7% in the control group (P = 0.001). Prevalences of MAC were 23.7%, 41.7%, 23.1%, and 3.4% (P < 0.001), respectively. Only 9 patients had claudication, and 6 of those patients had PAD. CONCLUSION: Both asymptomatic PAD and MAC are common in patients with CRF. Therefore, we recommend the use of both ABI and TBI measurements in the evaluation of PAD in patients with CRF. 相似文献